Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NG8Q
|
|||
| Drug Name |
Heteroaromatic ring derivative 2
|
|||
| Synonyms |
PMID28447479-Compound-17
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
FURMINGER, Vikki HUGHES, Owen LEGRAND, Darren STANLEY, Emily THOMSON, Christopher WILLIAMS, Gareth NOVARTIS ANOVARTIS AG FURMINGER, Vikki HUGHES, Owen THOMSON, Christopher LEGRAND, Darren, Mark STANLEY, Emil
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H23Cl2N5O3
|
|||
| Canonical SMILES |
C1CN(CCC1NC(=O)CCCC2=NNN=C2)C(=O)OCC3=CC(=CC(=C3)Cl)Cl
|
|||
| InChI |
1S/C19H23Cl2N5O3/c20-14-8-13(9-15(21)10-14)12-29-19(28)26-6-4-16(5-7-26)23-18(27)3-1-2-17-11-22-25-24-17/h8-11,16H,1-7,12H2,(H,23,27)(H,22,24,25)
|
|||
| InChIKey |
GAMSNABJTRSYDT-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Extracellular lysophospholipase D (E-NPP2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Extracellular lysophospholipase D (E-NPP2) | Target's Patent Info | [1] | |
| KEGG Pathway | Ether lipid metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.